GABA (g-aminobutyric acid), the major inhibitory transmitter in the brain, goes through a transitory phase of excitation during development. The excitatory phase promotes neuronal growth and integration into circuits. We show here that spontaneous nicotinic cholinergic activity is responsible for terminating GABAergic excitation and initiating inhibition. It does so by changing chloride transporter levels, shifting the driving force on GABA-induced currents. The timing of the transition is critical, because the two phases of GABAergic signaling provide contrasting developmental instructions. Synergistic with nicotinic excitation, GABAergic inhibition constrains neuronal morphology and innervation. The results reveal a multitiered activity-dependent strategy controlling neuronal development.
G ABA (g-aminobutyric acid) is the main inhibitory neurotransmitter in the adult brain, but GABAergic transmission is excitatory during early stages of development because of a reversed chloride gradient (1) (2) (3) . The GABAergic excitatory period is critical for neuronal maturation and integration into circuits during embryonic development and after adult neurogenesis (2, (4) (5) (6) . Despite the profound impact of the GABAergic excitation/inhibition transition on the nervous system, little is known about mechanisms that determine the timing of the transition or about possible developmental consequences of subsequent inhibitory GABAergic input. We show here that endogenous nicotinic cholinergic activity drives maturation of GABAergic signaling, determining when it becomes inhibitory. Further, early GABAergic inhibition interacts synergistically with nicotinic cholinergic signaling to guide subsequent development in new directions. These are unexpected consequences of spontaneous nicotinic activity.
Pharmacological blockade of nicotinic acetylcholine receptors (nAChRs) in vivo revealed the effects of spontaneous nicotinic cholinergic activity on GABAergic maturation. An informative example is the chick ciliary ganglion (CG), which receives nicotinic synaptic input from the accessory oculomotor nucleus and innervates smooth and striated muscle in the eye (7) . In addition to nAChRs, CG neurons express GABA A receptors (8) and, we find, receive GABAergic input ( fig. S1 ). GABAergic excitation in developing neurons can be visualized by loading cells with the calcium fluor fluo-3AM and challenging with GABA (9) . The resulting depolarization triggers calcium influx through voltage-gated calcium channels (VGCCs), causing fluorescence. GABA induced fluorescent responses in freshly dissociated embryonic day 9 (E9) CG neurons loaded with fluo-3AM (Fig. 1, A to C) . Fewer neurons from older ganglia displayed GABA-induced fluorescence; by E14 the response was almost gone. The decrease was not due to loss of VGCCs (Fig. 1, A and B) or GABA A receptors but rather to a loss of depolarizing GABA responses. Unexpectedly, this developmental change was prevented by the application of nicotinic antagonists in ovo. Blockade of nAChRs containing a7 subunits (a7-nAChRs) with either 100 nM a-bungarotoxin (aBgt) or 20 nM methyllycaconitine (MLA) at E8 caused more than a third of E14 neurons to retain a GABA-induced calcium response (Fig.  1D) a3-containing receptors (a3*-nAChRs)] with 5 mM dihydro-b-erythroidine (DHbE) had a similar effect. Combining blockers for the two receptor types completely prevented loss of the GABA-induced fluorescence response (Fig. 1D ). No morphological differences or changes in body weight were apparent for MLA/DHbEtreated embryos versus vehicle-treated controls.
The loss of GABA-induced calcium fluorescence resulted from maturation of the chloride gradient. Patch-clamp recording from E14 neurons in voltage-clamp mode using the perforated patch technique to preserve the endogenous chloride gradient revealed GABA responses with highly negative reversal potentials (-63.7 ± 1.3 mV; mean ± SEM, n = 7) (Fig. 1 , E to G). In contrast, E14 neurons from embryos blocked with MLA and DHbE at E8 in ovo had a more depolarized reversal potential for the GABA response (-44.1 ± 7.2 mV) ( Fig. 1 , E to G), as expected for immature neurons. Western blot analysis of E14 CGs from controls and MLA/DHbE-treated embryos showed that nicotinic blockade enabled ganglia to retain much higher levels of the embryonic chloride transporter NKCC1 (Fig. 1 , H and I), which produces the depolarizing chloride gradients found early in development (1, 3) . We conclude that blockade of nicotinic transmission between E8 and E14 prevents maturation of the chloride gradient in part by maintaining high levels of NKCC1.
To evaluate the pervasiveness of nicotinic effects on GABAergic maturation, we examined central nervous system populations. Freshly dissociated chick spinal cord neurons loaded with fluo-3AM were challenged with GABA plus glycine, the predominant inhibitory transmitters in the adult spinal cord. Whereas more than 75% of E6 neurons had GABA/glycine-induced calcium responses, less than 10% did so at E9 (fig. S2 ). Treating the embryos with MLA/DHbE from E3 in ovo caused nearly half of the neurons to retain GABA/glycine-induced calcium rsponses at E9. Hence, endogenous nicotinic activity helps drive conversion of GABAergic excitation to inhibition in spinal cord neurons.
In rodent hippocampal neurons, the GABAergic conversion occurs during the first weeks of postnatal life, a time when a7-nAChRs reach peak levels in the tissue (10, 11) . The a7-nAChR has a high relative calcium permeability (12) , and calcium influx promotes GABAergic conversion by increasing expression of the chloride transporter KCC2 that decreases intracellular chloride (13) . Accordingly, we compared hippocampal neurons from wild-type and mutant mice lacking a functional a7-nAChR gene (14) . Freshly dissociated wild-type neurons displayed GABA-induced calcium elevations at postnatal day 6 (P6), whereas less than 20% did so at P13 (Fig. 2A) . Hippocampal neurons from a7-nAChR knockout (KO) mice showed a very different profile. Most retained the excitatory GABA response at P9, and more than 50% still displayed it at P13 ( Fig. 2A) .
A depolarizing chloride gradient resulting from an immature expression pattern of chloride transporters in hippocampal cells again appeared to be responsible for the extended period of GABAergic excitation. Western blot analysis indicated that hippocampal tissue from a7 KO mice had higher levels of NKCC1 (Fig. 2B ) and lower levels of KCC2 (Fig. 2C) than did age-matched wild-type tissue. The results suggest that deletion of a7-nAChRs causes the cells to retain an immature expression pattern of chloride transporters (high NKCC1, low KCC2) (1, 3, 11) .
GABAergic inhibition, we find, plays an active role during development, enabling nicotinic excitation to guide neuronal development in a S3 ). Forcing expression of KCC2 by transfecting a construct encoding KCC2 fused to green fluorescent protein (KCC2/GFP) eliminated the GABA-induced calcium fluorescence as expected ( fig. S3 ). Striking morphological differences were found for KCC2/GFP-expressing neurons after chronic exposure to GABA. They became unipolar in culture as found in vivo. If GABA was omitted or if GFP was expressed in the neurons instead of KCC2/GFP, the neurons remained multipolar (Fig. 3A-C) . Notably, the GABAinduced morphological change required nicotinic activity: Including MLA and DHbE in the medium to block a7-and a3*-nAChRs, respectively, for the 6-day period prevented the change (Fig. 3D ). Neurons treated with the nicotinic blockers alone remained multipolar (not different from GFP).
A similar pattern emerged when synaptic contacts positioned on the neurons were examined. Staining for SV2 as a presynaptic marker revealed puncta on E8 neurons grown in culture for 6 days. Chronically treating KCC2/GFP-expressing neurons with GABA reduced the number of SV2 puncta compared with those found on untransfected neighboring cells (Fig. 3, E and F) . No reduction was seen for neurons expressing GFP or for KCC2/GFP-expressing neurons treated with the GABA A receptor antagonist gabazine instead of GABA (Fig. 3F) . Adding MLA and DHbE to the culture medium prevented the GABA-induced reduction of SV2 puncta on KCC2/GFPexpressing neurons but had no effect on the levels seen when gabazine was substituted for GABA (Fig. 3F) . The results show that again GABAergic inhibition and nicotinic excitation must combine to produce the changes.
How might this occur? Nicotinic activity can regulate gene expression in chick CG neurons but only if VGCCs fail to activate (16) . Inhibitory GABAergic signaling could prevent nicotinic transmission from activating VGCCs. Evidence for this was obtained by examining the ability of nicotine to induce sustained activation of the transcription factor CREB [cyclic adenosine monophosphate (cAMP) response element-binding protein] under conditions previously shown to correlate with nicotine-induced changes in gene expression (16) . VGCC blockers such as cadmium enable nicotine to activate CREB in freshly dissociated E14 neurons. GABA substituted for cadmium in this respect, acting through GABA A receptors; gabazine prevented the GABA effect ( fig. S4A) . GABA was unable to support nicotine-induced CREB activation in neurons that had depolarizing GABA responses ( fig. S4B) . Thus, E14 neurons from embryos treated with MLA and DHbE at E8 in ovo did not show activated CREB when treated with nicotine plus GABA but could still do so in response to nicotine plus cadmium (fig.  S4B) . The results are consistent with GABAergic inhibition sufficiently suppressing VGCC activation to permit nicotinic alteration of gene expression ( fig. S5) (16) .
To determine whether GABAergic inhibition and nicotinic excitation also act synergistically to guide development in vivo, we electroporated the KCC2/GFP construct into chick CG precursors at E1.5 in ovo (17) . Imaging CG sections at E14 revealed neurons expressing the construct. The small, round choroid cells that make up half of the neurons in the ganglion expressed normal numbers of a7-nAChR clusters but received few presynaptic boutons marked by SV2 staining (Fig. 4, A to D) . Choroid neurons transfected with the GFP construct, in contrast, had normal levels of SV2 puncta on the soma (Fig. 4 , E to H). Early expression of KCC2, together with GABAergic input, apparently depressed innervation of choroid neurons. The critical experiment then involved replicating the KCC2/GFP electroporation at E1.5, applying the nicotinic blockers MLA and DHbE to the embryo at E3, and isolating the cells at E14 for testing. The nicotinic blockers prevented the reduction in SV2 puncta (Fig. 4, I to L). Quantifying either the total amount of SV2 staining associated with boutons (Fig. 4M) or the number of SV2-stained boutons (Fig. 4N) yielded the same conclusions.
The results show that endogenous nicotinic activity acts broadly throughout the nervous system to convert GABAergic signaling from excitation to inhibition in developing neurons. The mechanism is likely to involve a change in chloride transporter levels, making the equilibrium potential for chloride currents more negative. In some cases, the GABAergic conversion may be mediated directly by activation of a7-nAChRs on the cells, given the presence of the receptors at the relevant time, their ability to be activated both by choline and acetylcholine, and their high relative permeability to calcium (10, 12, 18, 19) . In other cases, the effect may be indirect, acting perhaps through excitatory GABAergic projections. In the hippocampus, a7-nAChRs are most prominent on interneurons (20) , and GABAergic excitatory input can facilitate GABAergic conversion (13) . Repetitive spontaneous waves of excitation, driven initially by nicotinic activity and dependent on GABA/glycine, spread throughout the retina and spinal cord during development and influence the pattern of connections formed (21) (22) (23) (24) . The developing hippocampus also has spontaneous waves dependent on GABAergic excitation and subject to nicotinic modulation (25, 26) .
Previous work showed that GABAergic excitation is important for early neuronal development and integration into circuits (2, 4-6). Our findings indicate that GABAergic inhibition, in concert with nicotinic excitation, is important for later stages of development. In the CG this is likely to result from GABA suppressing VGCC activation during nicotinic excitation, a condition that enables nicotinic input to alter gene expression in the ganglion (16) . Because calcium influx is a common mechanism by which excitation influences neuronal development and because the amount and distribution of calcium influx is critical for the outcome (27, 28) , the ability of GABAergic in- Values represent mean ± SEM (n = 12 to 16 cultures per condition from six to eight experiments; 60 to 300 neurons per condition). Scale bars, 20 mm in (A) to (C), 10 mm in (E). *, P < 0.001 in (D), P < 0.01 in (F), by ANOVA. Fig. 4 . Early expression of KCC2 in ovo reduces innervation of choroid neurons unless nicotinic activity is blocked. Neurons electroporated at E1.5 in ovo with KCC2-GFP (A to D), GFP (E to H), or KCC2-GFP and treated with MLA/DHbE (I to L) were imaged at E14 in CG sections after staining for a7-nAChRs and SV2 and merging the images (horizontal rows). Arrows indicate blow-ups. The total amount of SV2 puncta staining (M) and the number of SV2 puncta (N) on the electroporated cell were normalized to that found on adjacent untransfected cells of equivalent size. Scale bar, 20 mm. Values represent mean ± SEM (n = number of electroporated neurons). *, P < 0.05 for (M), P < 0.001 for (N), by ANOVA.
hibition to restrict VGCC participation may be an important determinant of development in many pathways. Prime candidates would be pathways employing calcium-permeable AMPA (29) and N-methyl-D-aspartate receptors. The timing of the GABAergic switch determines when one set of developmental influences ends and another set begins. This layered sequence of activity may be a common feature where excitation shapes multiple stages of development. 
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